Orthobiologics

Orthobiologics Market by Type (Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix), Application (Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries), End-User - Global Forecast 2024-2030

SKU
MRR-036C5CF3B4C3
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 6.61 billion
2030
USD 10.43 billion
2024
USD 7.05 billion
CAGR
6.73%
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the orthobiologics market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[191 Pages Report] The Orthobiologics Market size was estimated at USD 6.61 billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 6.73% to reach USD 10.43 billion by 2030.

Orthobiologics Market
To learn more about this report, request a free PDF copy
Orthobiologics refers to the use of biological substances, such as growth factors, cell therapy, and tissue engineering, to help heal bones, muscles, and ligaments more quickly and effectively. These substances are frequently used in the treatment of orthopedic injuries and are derived from substances naturally found in the body, offering an innovative approach to accelerate the healing process in various orthopedic conditions. The primary drivers propelling the orthobiologics industry include the rising prevalence of sports injuries and orthopedic diseases, an aging population susceptible to osteoarthritis, and advancements in biotechnology that enable the development of new and effective treatments. Additionally, the rising preference for minimally invasive procedures and the growing awareness of the potential of regenerative medicine are further contributing to industry growth. However, the orthobiologics industry encounters certain restraints, such as high treatment costs and stringent regulatory requirements for product approval, which can impede industry growth. Challenges such as the lack of standardized guidelines and the potential for adverse reactions or complications pose significant hurdles. Moreover, the orthobiologics sector includes ample opportunities, notably through the continuous research and development activities aimed at introducing innovative products. Furthermore, there is a significant potential for industry expansion in emerging economies, driven by improving healthcare infrastructure and increasing patient awareness regarding new treatment options. Therefore, the future of the orthobiologics sector is promising, offering substantial benefits for patients and healthcare providers.
Orthobiologics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Orthobiologics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Orthobiologics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Orthobiologics Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., Bioventus LLC, DePuy Synthes, Globus Medical, Inc., Harvest Technologies Corporation, Kuros Biosciences Ltd., Nuvasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Allografts
    • Bone Morphogenic Proteins
    • Demineralised Bone Matrix
    • Joint Fluid Therapy
    • Soft Tissue Repair
    • Stem Cell Therapies
    • Synthetic Bone Grafts
  • Application
    • Fracture Recovery
    • Reconstructive Surgery
    • Soft-Tissue Injuries
    • Spinal Fusion
    • Trauma Repair
  • End-User
    • Dental Clinics & Facilities
    • Hospitals
    • Research & Academic Institutes

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Orthobiologics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Orthobiologics Market?
  3. What are the technology trends and regulatory frameworks in the Orthobiologics Market?
  4. What is the market share of the leading vendors in the Orthobiologics Market?
  5. Which modes and strategic moves are suitable for entering the Orthobiologics Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Orthobiologics Market, by Type
  7. Orthobiologics Market, by Application
  8. Orthobiologics Market, by End-User
  9. Americas Orthobiologics Market
  10. Asia-Pacific Orthobiologics Market
  11. Europe, Middle East & Africa Orthobiologics Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 298]
  16. List of Companies Mentioned [Total: 10]
Frequently Asked Questions
  1. How big is the Orthobiologics Market?
    Ans. The Global Orthobiologics Market size was estimated at USD 6.61 billion in 2023 and expected to reach USD 7.05 billion in 2024.
  2. What is the Orthobiologics Market growth?
    Ans. The Global Orthobiologics Market to grow USD 10.43 billion by 2030, at a CAGR of 6.73%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.